Skip to main content
. 2022 Oct 25;13:989717. doi: 10.3389/fphar.2022.989717

FIGURE 1.

FIGURE 1

(A) Chemical structure of CBD, THC, anandamide (AEA), and 2-arachidonoylglycerol (2AG). (B) CBD indirectly activates CB1 receptor and TRPV1 by inhibiting FAAH and thereby promoting the accumulation of AEA at synapse which may play a role in inhibiting glutamate-based excitotoxicity.